These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8020098)

  • 1. The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding.
    Robinson RC; Grey LM; Staunton D; Vankelecom H; Vernallis AB; Moreau JF; Stuart DI; Heath JK; Jones EY
    Cell; 1994 Jul; 77(7):1101-16. PubMed ID: 8020098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The crystal structure of murine leukemia inhibitory factor.
    Robinson RC; Grey LM; Staunton D; Stuart DI; Heath JK; Jones EY
    Ann N Y Acad Sci; 1995 Jul; 762():179-87; discussion 187-8. PubMed ID: 7668528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
    Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
    J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-species chimeras of leukaemia inhibitory factor define a major human receptor-binding determinant.
    Owczarek CM; Layton MJ; Metcalf D; Lock P; Willson TA; Gough NM; Nicola NA
    EMBO J; 1993 Sep; 12(9):3487-95. PubMed ID: 8253075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
    Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
    J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit.
    Tanaka M; Hara T; Copeland NG; Gilbert DJ; Jenkins NA; Miyajima A
    Blood; 1999 Feb; 93(3):804-15. PubMed ID: 9920829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-species chimeras of leukemia inhibitory factor define a human receptor binding site.
    Owczarek CM; Layton MJ; Metcalf D; Clark R; Gough NM; Nicola NA
    Ann N Y Acad Sci; 1995 Jul; 762():165-78. PubMed ID: 7668527
    [No Abstract]   [Full Text] [Related]  

  • 8. Binding interactions of leukemia inhibitory factor and ciliary neurotrophic factor with the different subunits of their high affinity receptors.
    Robledo O; Auguste P; Coupey L; Praloran V; Chevalier S; Pouplard A; Gascan H
    J Neurochem; 1996 Apr; 66(4):1391-9. PubMed ID: 8627290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF.
    Bitard J; Daburon S; Duplomb L; Blanchard F; Vuisio P; Jacques Y; Godard A; Heath JK; Moreau JF; Taupin JL
    J Biol Chem; 2003 May; 278(18):16253-61. PubMed ID: 12601009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex.
    Pennica D; Shaw KJ; Swanson TA; Moore MW; Shelton DL; Zioncheck KA; Rosenthal A; Taga T; Paoni NF; Wood WI
    J Biol Chem; 1995 May; 270(18):10915-22. PubMed ID: 7738033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex binding of leukemia inhibitory factor to its membrane-expressed and soluble receptors.
    Layton MJ; Owczarek CM; Metcalf D; Lock PA; Wilson TA; Gough NM; Hilton DJ; Nicola NA
    Proc Soc Exp Biol Med; 1994 Jul; 206(3):295-8. PubMed ID: 8016167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.
    Ichihara M; Hara T; Kim H; Murate T; Miyajima A
    Blood; 1997 Jul; 90(1):165-73. PubMed ID: 9207450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor recognition sites of cytokines are organized as exchangeable modules. Transfer of the leukemia inhibitory factor receptor-binding site from ciliary neurotrophic factor to interleukin-6.
    Kallen KJ; Grötzinger J; Lelièvre E; Vollmer P; Aasland D; Renné C; Müllberg J; Myer zum Büschenfelde KH; Gascan H; Rose-John S
    J Biol Chem; 1999 Apr; 274(17):11859-67. PubMed ID: 10207005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor.
    Gearing DP; Ziegler SF; Comeau MR; Friend D; Thoma B; Cosman D; Park L; Mosley B
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1119-23. PubMed ID: 8302840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes.
    Thoma B; Bird TA; Friend DJ; Gearing DP; Dower SK
    J Biol Chem; 1994 Feb; 269(8):6215-22. PubMed ID: 8119965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The soluble interleukin-6 receptor.
    Rose-John S; Ehlers M; Grötzinger J; Müllberg J
    Ann N Y Acad Sci; 1995 Jul; 762():207-20; discussion 220-1. PubMed ID: 7668529
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of ciliary neurotrophic factor (CNTF) residues essential for leukemia inhibitory factor receptor binding and generation of CNTF receptor antagonists.
    Di Marco A; Gloaguen I; Graziani R; Paonessa G; Saggio I; Hudson KR; Laufer R
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9247-52. PubMed ID: 8799186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M is a differentiation factor for myeloid leukemia cells.
    Bruce AG; Hoggatt IH; Rose TM
    J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.